Drug Profile
Research programme: PPAR gamma partial agonists - Kyorin Pharmaceutical
Alternative Names: PAA-3352Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Kyorin Pharmaceutical
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in Japan
- 10 Apr 2007 Preclinical trials in Type-2 diabetes mellitus in Japan (unspecified route)